The Renal Diseases Market is expected to register a CAGR of 5.41% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Disease Type (Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Disease); Treatment Type (Dialysis, Medication, Kidney Transplantation, Surgery, Diet, Others); Diagnosis (Blood tests, Imaging Tests, Biopsy, Urine tests, Others) and End User (Dialysis Centers, Hospital and Clinics, Research and Academic Institutes). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Renal Diseases Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Renal Diseases Market Segmentation
Disease Type- Chronic Kidney Disease
- End-Stage Renal Disease
- Acute Kidney Disease
- Dialysis
- Medication
- Kidney Transplantation
- Surgery
- Diet
- Blood tests
- Imaging Tests
- Biopsy
- Urine tests
- Dialysis Centers
- Hospital and Clinics
- Research and Academic Institutes
Strategic Insights
Renal Diseases Market Growth Drivers- Increasing Prevalence of Chronic Kidney Disease (CKD): The rising prevalence of chronic kidney disease (CKD) is one of the most significant growth drivers for the renal diseases market. Kidney-related disorders including CKD are becoming more common as people around the world grow older. The leading factors of CKD include diabetes and hypertension together with obesity which are both rising in global prevalence. The World Health Organization (WHO) now considers CKD an urgent public health challenge because it leads to several fatal complications like cardiovascular disease. While developed countries see growing CKD rates in aging populations developed nations witness higher CKD cases among older people while developing regions experience kidney disease spikes due to rising diabetes and hypertension cases. Early detection and management of CKD helps slow disease progression which creates higher demand for renal disease treatments and monitoring solutions. The renal diseases market is experiencing significant growth because healthcare systems are now emphasizing early diagnosis along with individualized treatment methods to enhance patient outcomes. Non-invasive diagnostic methods like biomarker tests and imaging help detect kidney problems earlier which boosts demand for pharmaceuticals and treatments targeting kidney function and management. The renal diseases market growth is anticipated because CKD global prevalence keeps increasing which creates more demand for dialysis services, renal transplantation, and medications for kidney diseases.
- Advances in Dialysis Technologies: Developments in dialysis technologies act as a vital growth factor for the market addressing renal diseases. Hemodialysis and peritoneal dialysis stand as fundamental treatments for patients suffering from end-stage renal disease (ESRD). As more CKD patients advance to ESRD the requirement for dialysis services and products continues to expand. New technologies in dialysis machines and procedures have led to better patient results while shortening dialysis treatment times and improving patient comfort during process. New portable dialysis devices now allow patients to receive treatments in their homes which increases convenience and diminishes the necessity for hospital visits. Upgrades to dialyzers—the filters employed in dialysis procedures—have resulted in better treatment effectiveness and improved safety for patients. Dialysis technology advancements have produced compact devices which patients find easy to use and these devices improve patient life quality. Precise monitoring systems which track patients' vital signs and kidney function during dialysis sessions have produced additional improvements in patient care. The renal diseases market will continue to expand as technological improvements in dialysis match the growing need for services triggered by rising CKD and ESRD cases. Technological advancements have made home dialysis solutions more attractive because they give patients better control and comfort while managing their kidney disease.
- Growing Awareness and Early Detection of Kidney Disease: Renal diseases market expansion results from better early detection techniques and growing awareness of kidney disease. Healthcare organizations as well as advocacy groups have worked over time to promote awareness about kidney health alongside CKD risks and the benefits of early diagnosis. Early-stage kidney disease often presents no symptoms but early detection remains essential to stop progression to end-stage renal failure. Early detection of kidney disease is being improved through screening programs which target individuals at high risk such as those with hypertension and diabetes or with a family history of kidney disease. More accurate biomarkers and diagnostic tools now enable physicians to detect diseases early which results in timely interventions and improved patient outcomes. Medical professionals now detect kidney dysfunction at earlier stages due to improved testing methods like urine albumin-to-creatinine ratio (UACR) and glomerular filtration rate (GFR). Medical professionals have started to use more treatments designed to prevent CKD progression due to these developments. Better treatment options together with early detection are creating demand for renal disease medications and dialysis services as well as other healthcare solutions. Patients taking more initiative in kidney health management due to preventive care trends is expanding the renal diseases market.
- Growing Focus on Preventative Care and Early Intervention: The rising focus on preventive care and early intervention is the most significant trend in the renal diseases market. The healthcare systems have realized that the cost and burden of advanced kidney disease management are substantial, which urges them to concentrate more on stopping renal disease progression through early detection and proactive management measures. CKD remains a prominent problem as most patients do not experience symptoms until the disease progresses to a very advanced stage. High-risk patients with diabetes and hypertension can be screened regularly for early detection of kidney disease and, consequently, have better results in treatment. Early interventions through lifestyle modifications and, most importantly, the monitoring of kidney functions can progressively reduce the rate of disease progression and minimize very expensive treatments like dialysis or transplantation. Healthcare professionals pay more attention to educating patients on issues related to kidney functioning and encourage them to seek CKD screening even if asymptomatic. The progression towards preventive measures gets support from new biomarkers and diagnostic tools which allow for faster diagnosis with increased accuracy. Global health authorities and healthcare systems are implementing early intervention strategies to lessen both end-stage renal disease incidents and related medical expenditures through their public health planning. The market for renal diseases is shifting towards preventive care methods that protect kidneys from damage and enhance patient health outcomes which opens new avenues for pharmaceutical corporations and healthcare professionals.
- Increased Adoption of Telemedicine in Renal Disease Management: Patients suffering from renal disease can receive telemedicine where they can consult their doctors and change the treatment plans with the help of doctors without needing to visit a hospital physically. This trend has been beneficial to patients who are living in remote or under-served areas, as access to health care professionals and dialysis centers is usually very limited in those areas. Telemedicine platforms provide healthcare providers with constant access to real-time data from patients' vital signs and kidney function measurements which help them adjust treatment plans when necessary. Medical facilities are less strained due to the remote consultations which facilitate better medical resource management. Remote healthcare services will increase as they provide patients with better convenience, especially for those who need to undergo regular dialysis treatments. Health care for renal diseases will be more tailored and effective with wearable devices and mobile health applications working together with telemedicine to enhance patient engagement and the outcomes of the treatment.
- Rise in Home-Based Dialysis Solutions: Home-based dialysis solutions are emerging as a leading trend in the renal diseases market. Patients opt for home dialysis therapies like peritoneal dialysis (PD) and home hemodialysis (HHD) more often since these treatments are scheduled according to the patient's preference and offer them more control over the treatment process.
- Growth of Home-Based Dialysis Solutions: Patients who avoid hospital visits and reduce long sessions of dialysis find home dialysis solutions highly beneficial. Home dialysis machines have become portable and efficient because of technological advancement, which has led to this shift towards home-based care. With home dialysis, patient satisfaction increases as the chances of acquiring hospital-acquired infection reduce and the quality of life improves. Home dialysis is well appreciated by doctors and other health care systems since it ensures improved patient outcome and at the same time reduces the workload on the hospitals and dialysis centers. Home dialysis treatment of chronic kidney diseases will continue growing since more patients prefer individualized treatments that are convenient. Companies that sell home dialysis products and services will benefit greatly from this trend, which predicts a significant growth in demand for these solutions in future years.
- Targeted therapies and Novel Drug Therapy: One of the major growth opportunities for the market is targeted therapies and new drug treatments for renal diseases. Now, therapeutic options for kidney diseases are mainly symptomatic therapies as well as slowing the progression of the disease. However, research in molecular pathways related to kidney disease has opened the door to developing more specific treatments targeting the underlying causes of conditions like CKD, diabetic nephropathy, and glomerulonephritis. New drug candidates that can intervene at the molecular level, such as inhibitors of specific enzymes or receptors involved in kidney damage, are showing promise in clinical trials. Some studies also involve therapy in the area of kidney regeneration and protection from damage. Such therapy is targeted toward further effective drugs and possibly improved outcomes in patients while decreasing the duration of dialysis and transplantation. Thus, when researchers develop breakthroughs in these therapies, it sets a market in the hands of pharmaceutical companies specialized in renal disease therapies. This would mean the entry of new classes of drugs and biologics into the renal diseases market and contribute toward better outcomes for patients.
- Expanding Kidney Transplantation Programs: Kidney transplantation stands as one of the top treatments for patients suffering from end-stage renal disease (ESRD). The number of available donor kidneys falls short of the global need for kidney transplants which results in growth prospects for the renal diseases market. Organ donation systems are being improved while kidney transplant programs expand through the joint efforts of governments, healthcare organizations and non-profit organizations who also raise awareness about kidney donor needs. The availability of organs for transplant grows as paired kidney donation and living donor programs gain attention beyond traditional kidney transplantation. The kidney transplantation programs continue to expand because of advancements in immunosuppressive drugs along with better post-transplant care and improved diagnostic tools. The growing number of CKD and ESRD patients pushes kidney transplant needs higher which leads to market growth through expanded transplantation programs. The development of organ transplant technologies will lead to better efficiency and higher success rates for kidney transplants in the future. The renal diseases market is expected to grow positively.
- Innovations in Kidney Transplantation and Organ Preservation Technologies: The renal diseases market stands to gain from advances in kidney transplantation and organ preservation technologies. Medical care advancements haven't resolved the critical shortage of kidney donors which restricts kidney transplant availability for those suffering from end-stage renal disease (ESRD). Emerging technologies and methods for better organ preservation and higher transplant success rates offer numerous growth possibilities. The creation of improved organ preservation solutions has extended donor kidney viability during transport so more patients can receive expedited transplants. Machine perfusion techniques which maintain a kidney on a machine that circulates oxygenated fluids are markedly enhancing organ preservation methods and transplant results. The supply of organs is rising because genetic engineering and stem cell research enable organ regeneration and improve donor kidney compatibility which reduces rejection risks. The development of better kidney preservation techniques together with alternative kidney sources creates significant growth potential in the renal diseases market because kidney transplantation continues to be the best treatment for many patients suffering from ESRD. New immunosuppressive treatment methods that protect against organ rejection while reducing adverse effects lead to higher transplant success rates. Renal transplantation market growth continues to accelerate because of collaborative progress in organ preservation technology along with donor pool expansion and post-transplant therapy advancement.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Renal Diseases Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Renal Diseases Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Renal Diseases Market is estimated to witness a CAGR of 5.41% from 2025 to 2031.
The major factors driving the Renal Diseases Market are Increasing Prevalence of Chronic Kidney Disease (CKD), Advances in Dialysis Technologies, and Growing Awareness and Early Detection of Kidney Disease.
Future trends in the Renal Diseases Market are Growing Focus on Preventative Care and Early Intervention, Increased Adoption of Telemedicine in Renal Disease Management, and Growth of Home-Based Dialysis Solutions.
Some of the players operating in the market are Abbott, Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC,Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd.
The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.
Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Renal Disease Market - By Disease Type
1.3.2 Renal Disease Market - By Treatment Type
1.3.3 Renal Disease Market - By Diagnosis
1.3.4 Renal Disease Market - By End User
1.3.5 Renal Disease Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RENAL DISEASE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RENAL DISEASE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RENAL DISEASE MARKET - GLOBAL MARKET ANALYSIS
6.1. RENAL DISEASE - GLOBAL MARKET OVERVIEW
6.2. RENAL DISEASE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHRONIC KIDNEY DISEASE
7.3.1. Overview
7.3.2. Chronic Kidney Disease Market Forecast and Analysis
7.4. END-STAGE RENAL DISEASE (ESRD)
7.4.1. Overview
7.4.2. End-Stage Renal Disease (ESRD) Market Forecast and Analysis
7.5. ACUTE KIDNEY DISEASE
7.5.1. Overview
7.5.2. Acute Kidney Disease Market Forecast and Analysis
7.5.3. Prerenal Market
7.5.3.1. Overview
7.5.3.2. Prerenal Market Forecast and Analysis
7.5.4. Post renal Market
7.5.4.1. Overview
7.5.4.2. Post renal Market Forecast and Analysis
7.5.5. Renal Market
7.5.5.1. Overview
7.5.5.2. Renal Market Forecast and Analysis
8. RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. DIALYSIS
8.3.1. Overview
8.3.2. Dialysis Market Forecast and Analysis
8.3.3. Hemodialysis Market
8.3.3.1. Overview
8.3.3.2. Hemodialysis Market Forecast and Analysis
8.3.4. Peritoneal Dialysis Market
8.3.4.1. Overview
8.3.4.2. Peritoneal Dialysis Market Forecast and Analysis
8.4. MEDICATION
8.4.1. Overview
8.4.2. Medication Market Forecast and Analysis
8.4.3. High Blood Pressure Medications Market
8.4.3.1. Overview
8.4.3.2. High Blood Pressure Medications Market Forecast and Analysis
8.4.4. Lower Cholesterol Levels Medications Market
8.4.4.1. Overview
8.4.4.2. Lower Cholesterol Levels Medications Market Forecast and Analysis
8.4.5. Medications to Treat Anemia Market
8.4.5.1. Overview
8.4.5.2. Medications to Treat Anemia Market Forecast and Analysis
8.4.6. Medications to Relieve Swelling Market
8.4.6.1. Overview
8.4.6.2. Medications to Relieve Swelling Market Forecast and Analysis
8.4.7. Medications to Protect Bones Market
8.4.7.1. Overview
8.4.7.2. Medications to Protect Bones Market Forecast and Analysis
8.5. KIDNEY TRANSPLANTATION
8.5.1. Overview
8.5.2. Kidney Transplantation Market Forecast and Analysis
8.5.3. Deceased-donor Kidney Transplant Market
8.5.3.1. Overview
8.5.3.2. Deceased-donor Kidney Transplant Market Forecast and Analysis
8.5.4. Living-donor Kidney Transplant Market
8.5.4.1. Overview
8.5.4.2. Living-donor Kidney Transplant Market Forecast and Analysis
8.5.5. Pre-emptive Kidney Transplant Market
8.5.5.1. Overview
8.5.5.2. Pre-emptive Kidney Transplant Market Forecast and Analysis
8.6. SURGERY
8.6.1. Overview
8.6.2. Surgery Market Forecast and Analysis
8.6.3. Nephrectomy and Radical Nephrectomy Market
8.6.3.1. Overview
8.6.3.2. Nephrectomy and Radical Nephrectomy Market Forecast and Analysis
8.6.4. Nephron-Sparing Surgery (NSS) Market
8.6.4.1. Overview
8.6.4.2. Nephron-Sparing Surgery (NSS) Market Forecast and Analysis
8.6.5. Nephrolithotripsy Market
8.6.5.1. Overview
8.6.5.2. Nephrolithotripsy Market Forecast and Analysis
8.6.6. Extracorporeal Shock Wave Lithotripsy (ESWL) Market
8.6.6.1. Overview
8.6.6.2. Extracorporeal Shock Wave Lithotripsy (ESWL) Market Forecast and Analysis
8.6.7. Others Market
8.6.7.1. Overview
8.6.7.2. Others Market Forecast and Analysis
8.7. DIET
8.7.1. Overview
8.7.2. Diet Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS
9.1. OVERVIEW
9.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
9.3. BLOOD TESTS
9.3.1. Overview
9.3.2. Blood tests Market Forecast and Analysis
9.3.3. Serum Creatinine Market
9.3.3.1. Overview
9.3.3.2. Serum Creatinine Market Forecast and Analysis
9.3.4. Glomerular Filtration Rate (GFR) Market
9.3.4.1. Overview
9.3.4.2. Glomerular Filtration Rate (GFR) Market Forecast and Analysis
9.3.5. Blood Urea Nitrogen (BUN) Market
9.3.5.1. Overview
9.3.5.2. Blood Urea Nitrogen (BUN) Market Forecast and Analysis
9.3.6. Fasting Blood Glucose Test Market
9.3.6.1. Overview
9.3.6.2. Fasting Blood Glucose Test Market Forecast and Analysis
9.4. IMAGING TESTS
9.4.1. Overview
9.4.2. Imaging Tests Market Forecast and Analysis
9.4.3. Ultrasound Market
9.4.3.1. Overview
9.4.3.2. Ultrasound Market Forecast and Analysis
9.4.4. CT Scan Market
9.4.4.1. Overview
9.4.4.2. CT Scan Market Forecast and Analysis
9.5. BIOPSY
9.5.1. Overview
9.5.2. Biopsy Market Forecast and Analysis
9.6. URINE TESTS
9.6.1. Overview
9.6.2. Urine tests Market Forecast and Analysis
9.6.3. Urinalysis Market
9.6.3.1. Overview
9.6.3.2. Urinalysis Market Forecast and Analysis
9.6.4. Protein Urine Test Market
9.6.4.1. Overview
9.6.4.2. Protein Urine Test Market Forecast and Analysis
9.6.5. Microalbuminuria Test Market
9.6.5.1. Overview
9.6.5.2. Microalbuminuria Test Market Forecast and Analysis
9.6.6. Creatinine Clearance Test Market
9.6.6.1. Overview
9.6.6.2. Creatinine Clearance Test Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. DIALYSIS CENTERS
10.3.1. Overview
10.3.2. Dialysis Centers Market Forecast and Analysis
10.4. HOSPITAL AND CLINICS
10.4.1. Overview
10.4.2. Hospital and Clinics Market Forecast and Analysis
10.5. RESEARCH AND ACADEMIC INSTITUTES
10.5.1. Overview
10.5.2. Research and Academic Institutes Market Forecast and Analysis
11. RENAL DISEASE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Renal Disease Market Overview
11.1.2 North America Renal Disease Market Forecasts and Analysis
11.1.3 North America Renal Disease Market Forecasts and Analysis - By Disease Type
11.1.4 North America Renal Disease Market Forecasts and Analysis - By Treatment Type
11.1.5 North America Renal Disease Market Forecasts and Analysis - By Diagnosis
11.1.6 North America Renal Disease Market Forecasts and Analysis - By End User
11.1.7 North America Renal Disease Market Forecasts and Analysis - By Countries
11.1.7.1 United States Renal Disease Market
11.1.7.1.1 United States Renal Disease Market by Disease Type
11.1.7.1.2 United States Renal Disease Market by Treatment Type
11.1.7.1.3 United States Renal Disease Market by Diagnosis
11.1.7.1.4 United States Renal Disease Market by End User
11.1.7.2 Canada Renal Disease Market
11.1.7.2.1 Canada Renal Disease Market by Disease Type
11.1.7.2.2 Canada Renal Disease Market by Treatment Type
11.1.7.2.3 Canada Renal Disease Market by Diagnosis
11.1.7.2.4 Canada Renal Disease Market by End User
11.1.7.3 Mexico Renal Disease Market
11.1.7.3.1 Mexico Renal Disease Market by Disease Type
11.1.7.3.2 Mexico Renal Disease Market by Treatment Type
11.1.7.3.3 Mexico Renal Disease Market by Diagnosis
11.1.7.3.4 Mexico Renal Disease Market by End User
11.2. EUROPE
11.2.1 Europe Renal Disease Market Overview
11.2.2 Europe Renal Disease Market Forecasts and Analysis
11.2.3 Europe Renal Disease Market Forecasts and Analysis - By Disease Type
11.2.4 Europe Renal Disease Market Forecasts and Analysis - By Treatment Type
11.2.5 Europe Renal Disease Market Forecasts and Analysis - By Diagnosis
11.2.6 Europe Renal Disease Market Forecasts and Analysis - By End User
11.2.7 Europe Renal Disease Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Renal Disease Market
11.2.7.1.1 Germany Renal Disease Market by Disease Type
11.2.7.1.2 Germany Renal Disease Market by Treatment Type
11.2.7.1.3 Germany Renal Disease Market by Diagnosis
11.2.7.1.4 Germany Renal Disease Market by End User
11.2.7.2 France Renal Disease Market
11.2.7.2.1 France Renal Disease Market by Disease Type
11.2.7.2.2 France Renal Disease Market by Treatment Type
11.2.7.2.3 France Renal Disease Market by Diagnosis
11.2.7.2.4 France Renal Disease Market by End User
11.2.7.3 Italy Renal Disease Market
11.2.7.3.1 Italy Renal Disease Market by Disease Type
11.2.7.3.2 Italy Renal Disease Market by Treatment Type
11.2.7.3.3 Italy Renal Disease Market by Diagnosis
11.2.7.3.4 Italy Renal Disease Market by End User
11.2.7.4 Spain Renal Disease Market
11.2.7.4.1 Spain Renal Disease Market by Disease Type
11.2.7.4.2 Spain Renal Disease Market by Treatment Type
11.2.7.4.3 Spain Renal Disease Market by Diagnosis
11.2.7.4.4 Spain Renal Disease Market by End User
11.2.7.5 United Kingdom Renal Disease Market
11.2.7.5.1 United Kingdom Renal Disease Market by Disease Type
11.2.7.5.2 United Kingdom Renal Disease Market by Treatment Type
11.2.7.5.3 United Kingdom Renal Disease Market by Diagnosis
11.2.7.5.4 United Kingdom Renal Disease Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Renal Disease Market Overview
11.3.2 Asia-Pacific Renal Disease Market Forecasts and Analysis
11.3.3 Asia-Pacific Renal Disease Market Forecasts and Analysis - By Disease Type
11.3.4 Asia-Pacific Renal Disease Market Forecasts and Analysis - By Treatment Type
11.3.5 Asia-Pacific Renal Disease Market Forecasts and Analysis - By Diagnosis
11.3.6 Asia-Pacific Renal Disease Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Renal Disease Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Renal Disease Market
11.3.7.1.1 Australia Renal Disease Market by Disease Type
11.3.7.1.2 Australia Renal Disease Market by Treatment Type
11.3.7.1.3 Australia Renal Disease Market by Diagnosis
11.3.7.1.4 Australia Renal Disease Market by End User
11.3.7.2 China Renal Disease Market
11.3.7.2.1 China Renal Disease Market by Disease Type
11.3.7.2.2 China Renal Disease Market by Treatment Type
11.3.7.2.3 China Renal Disease Market by Diagnosis
11.3.7.2.4 China Renal Disease Market by End User
11.3.7.3 India Renal Disease Market
11.3.7.3.1 India Renal Disease Market by Disease Type
11.3.7.3.2 India Renal Disease Market by Treatment Type
11.3.7.3.3 India Renal Disease Market by Diagnosis
11.3.7.3.4 India Renal Disease Market by End User
11.3.7.4 Japan Renal Disease Market
11.3.7.4.1 Japan Renal Disease Market by Disease Type
11.3.7.4.2 Japan Renal Disease Market by Treatment Type
11.3.7.4.3 Japan Renal Disease Market by Diagnosis
11.3.7.4.4 Japan Renal Disease Market by End User
11.3.7.5 South Korea Renal Disease Market
11.3.7.5.1 South Korea Renal Disease Market by Disease Type
11.3.7.5.2 South Korea Renal Disease Market by Treatment Type
11.3.7.5.3 South Korea Renal Disease Market by Diagnosis
11.3.7.5.4 South Korea Renal Disease Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Renal Disease Market Overview
11.4.2 Middle East and Africa Renal Disease Market Forecasts and Analysis
11.4.3 Middle East and Africa Renal Disease Market Forecasts and Analysis - By Disease Type
11.4.4 Middle East and Africa Renal Disease Market Forecasts and Analysis - By Treatment Type
11.4.5 Middle East and Africa Renal Disease Market Forecasts and Analysis - By Diagnosis
11.4.6 Middle East and Africa Renal Disease Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Renal Disease Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Renal Disease Market
11.4.7.1.1 South Africa Renal Disease Market by Disease Type
11.4.7.1.2 South Africa Renal Disease Market by Treatment Type
11.4.7.1.3 South Africa Renal Disease Market by Diagnosis
11.4.7.1.4 South Africa Renal Disease Market by End User
11.4.7.2 Saudi Arabia Renal Disease Market
11.4.7.2.1 Saudi Arabia Renal Disease Market by Disease Type
11.4.7.2.2 Saudi Arabia Renal Disease Market by Treatment Type
11.4.7.2.3 Saudi Arabia Renal Disease Market by Diagnosis
11.4.7.2.4 Saudi Arabia Renal Disease Market by End User
11.4.7.3 U.A.E Renal Disease Market
11.4.7.3.1 U.A.E Renal Disease Market by Disease Type
11.4.7.3.2 U.A.E Renal Disease Market by Treatment Type
11.4.7.3.3 U.A.E Renal Disease Market by Diagnosis
11.4.7.3.4 U.A.E Renal Disease Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Renal Disease Market Overview
11.5.2 South and Central America Renal Disease Market Forecasts and Analysis
11.5.3 South and Central America Renal Disease Market Forecasts and Analysis - By Disease Type
11.5.4 South and Central America Renal Disease Market Forecasts and Analysis - By Treatment Type
11.5.5 South and Central America Renal Disease Market Forecasts and Analysis - By Diagnosis
11.5.6 South and Central America Renal Disease Market Forecasts and Analysis - By End User
11.5.7 South and Central America Renal Disease Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Renal Disease Market
11.5.7.1.1 Brazil Renal Disease Market by Disease Type
11.5.7.1.2 Brazil Renal Disease Market by Treatment Type
11.5.7.1.3 Brazil Renal Disease Market by Diagnosis
11.5.7.1.4 Brazil Renal Disease Market by End User
11.5.7.2 Argentina Renal Disease Market
11.5.7.2.1 Argentina Renal Disease Market by Disease Type
11.5.7.2.2 Argentina Renal Disease Market by Treatment Type
11.5.7.2.3 Argentina Renal Disease Market by Diagnosis
11.5.7.2.4 Argentina Renal Disease Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RENAL DISEASE MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. RENAL DISEASE MARKET, KEY COMPANY PROFILES
14.1. ABBOTT
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. AMGEN INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ASTRAZENECA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BRISTOL-MYERS SQUIBB COMPANY
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. F. HOFFMANN-LA ROCHE LTD
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. GLAXOSMITHKLINE PLC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. NOVARTIS AG
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. PFIZER INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. SANOFI SA
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. TEVA PHARMACEUTICAL INDUSTRIES LTD
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Abbott
2. Amgen Inc
3. AstraZeneca
4. Bristol-Myers Squibb Company
5. F. Hoffmann-La Roche Ltd
6. GlaxoSmithKline PLC
7. Novartis AG
8. Pfizer Inc.
9. Sanofi SA
10. Teva Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For